USPSTF2018EN
Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement.
Zusammenfassung
US PREVENTIVE SERVICES TASK FORCE RECOMMENDATION STATEMENT
TITLE: Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement.
PUBLICATION: JAMA, 2018
PMID: 29998297
RECOMMENDATION SUMMARY:
Cardiovascular disease (CVD) is the most common cause of death among adults in the United States. Treatment to prevent CVD events by modifying risk factors is currently informed by the Framingham Risk Score, the Pooled Cohort Equat
Kerninformationen
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of adding the ABI, hsCRP level, or CAC score to traditional risk assessment for CVD in asymptomatic adults to prevent CVD events. (I statement). SOURCE: US Preventive Services Task Force
EVIDEN...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
USPSTF2018
Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement.
USPSTF2018
Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement.
USPSTF2022
Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement.
USPSTF2022
USPSTF Recommendation: Statin Use for Primary Prevention of CVD
USPSTF2021
Screening for Asymptomatic Carotid Artery Stenosis: US Preventive Services Task Force Recommendation Statement.
USPSTF2022
Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement.
USPSTF2022
Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement.
USPSTF2019